Record overview
Status and phase
Status: TERMINATED
Phase: PHASE2
Sponsor: Duke University
Condition: Prostate Cancer
NCT00918385
Genomic Guided Therapy With Dasatinib or Nilutamide in Metastatic Castration-Resistant Prostate Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: rare_population_signal | strict_eligibility_signal | complex_intervention_signal
Stopped reason
Context when available
Permanent closure of trial to further accrual based on IDE disapproval